United States Medical Devices news | Sharemaestro Newsreel

14:30 13 Aug 2026

finance.yahoo.com Analyst action Provider-linked mention 🇺🇸 United States

Wall Street Bulls Look Optimistic About Medtronic (MDT): Should You Buy?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before …

MDT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -4.1%

14:30 13 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Let's take a look at what these …

BSX main company

Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.9%

14:29 13 Aug 2026

finance.yahoo.com Deals and strategy Provider-linked mention 🇺🇸 United States

Can BWX Technologies' Nuclear Medicine Expansion Boost Growth?

BWX Technologies, Inc. BWXT is broadening its commercial nuclear portfolio through expanded capabilities in nuclear medicine and medical radioisotopes. The company's acquisition of Kinectrics in May 2025 added capabilities in the production and supply of isotopes for the radiopharmaceutical industry, enabling BWXT to expand …

GEHC mentioned

Sharemaestro market context Price above Trend Line 52 weeks -2.1%

14:17 13 Aug 2026

nasdaq.com Earnings Main company 🇺🇸 United States

Bioventus (BVS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Rob ClaypooleSenior Vice President and Chief Financial Officer - Mark SingletonInvestor Relations - Dave Crawford TAKEAWAYS Revenue -- $153.2 million, an increase …

BVS main company

Sharemaestro market context Trend signal active 52 weeks +91.7% · Next-week setup positive 56.5%

14:14 13 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Here’s What Hurt Boston Scientific Corporation (BSX) in Q2

TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve …

BSX main company

Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.9%

14:14 13 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

ABT main company

Sharemaestro market context Price above Trend Line 52 weeks -16.9%

14:11 13 Aug 2026

TipRanks Earnings Main company 🇺🇸 United States

Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings Report - Results, Call & Slides

Alamar Biosciences, Inc. (ALMR) reported its Q2 2026 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of -$0.22 against a consensus of -$0.31, and actual revenue of $29.40 million compared to an expected $25.86 million. The earnings call took …

ALMR main company

Sharemaestro market context Stored weekly price path 17 weeks +29.4%

14:10 13 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Inspire Medical Systems (INSP): Soleus Capital group reports 6.7% ownership stake

Soleus Capital Master Fund, L.P. and affiliated entities have reported a 6.7% ownership stake in Inspire Medical Systems, Inc. (INSP), holding 1,931,436 shares of common stock. This beneficial ownership is based on 28,910,375 shares outstanding as of July 30, 2026, and grants shared voting …

INSP main company

Sharemaestro market context New activity signal 52 weeks -31.5%

14:10 13 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates

Lucid Diagnostics Inc. (LUCD) reported a wider-than-expected Q2 loss of $0.06 per share, missing the Zacks Consensus Estimate of a $0.04 loss, and its revenues of $1.47 million also fell short of estimates. The company has underperformed the S&P 500 year-to-date, and its shares …

LUCD main company

Sharemaestro market context Price below Trend Line 52 weeks -5.2%

14:10 13 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

Earnings call transcript: Lucid Diagnostics posts Q2 2026 revenue beat, shares slip

Lucid Diagnostics (LUCD) reported a Q2 2026 revenue beat of $1.47 million, surpassing expectations by 2.8%, though shares slipped slightly. The company matched Wall Street forecasts with a loss of 6 cents per share, and its EsoGuard test volume remained within target. Management highlighted …

LUCD main company

Sharemaestro market context Price below Trend Line 52 weeks -5.2%

14:04 13 Aug 2026

finance.yahoo.com Market update Main company 🇺🇸 United States

Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the "Insiders Fund". A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% …

PODD main company

Sharemaestro market context Price below Trend Line 52 weeks -56.1%

14:00 13 Aug 2026

ACCESS Newswire Regulatory and legal Main company 🇺🇸 United States

Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against AdaptHealth Corp. (AHCO) after the company reported significantly lower-than-expected Q2 2026 revenue and adjusted EBITDA, along with a substantial reduction in full-year guidance. The firm encourages investors who purchased AdaptHealth securities to connect with …

AHCO main company

Sharemaestro market context Price below Trend Line 52 weeks -40.0%

14:00 13 Aug 2026

finance.yahoo.com Guidance Provider-linked mention 🇺🇸 United States

Priori Expands Client Advisory Board with New Members from Fortune 500 Corporate Legal Departments

Priori Legal operations and legal department leaders from Mastercard, Meta, Google, Uber, General Motors, U.S. Bank, Capital One and more will help shape the future of outside counsel management NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Priori, the legal technology company modernizing outside …

SYK mentioned

Sharemaestro market context Price above Trend Line 52 weeks -10.6%

13:51 13 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation

Edwards Lifesciences Corporation EW shares have gained 14% in the past three months as growth across its structural-heart franchises has strengthened the operating case. Second-quarter results showed double-digit expansion in transcatheter aortic valve replacement and faster growth in transcatheter mitral and tricuspid therapies. The …

EW main company MDT mentioned BSX mentioned

Sharemaestro market context Trend signal active 52 weeks +14.6% · Next-week setup negative 42.0%

13:49 13 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

ABT main company MDT mentioned BSX mentioned

Sharemaestro market context Price above Trend Line 52 weeks -16.9%

13:48 13 Aug 2026

Simply Wall Street Capital return Main company 🇺🇸 United States

Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ (ZBH) Narrative

Zimmer Biomet Holdings (ZBH) reported strong Q2 2026 results, including US$2,177 million in sales and US$198.3 million in net income, alongside completing a US$496.84 million share buyback. Management also raised full-year guidance due to robust performance in its hip and technology segments. This move …

ZBH main company

Sharemaestro market context Price above Trend Line 52 weeks -5.1%

13:42 13 Aug 2026

PR Newswire Market update Main company 🇺🇸 United States

IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation

IceCure Medical announced two new peer-reviewed publications that support the increasing role of cryoablation in breast cancer treatment de-escalation. One review highlights ProSense®'s FDA authorization, ASBrS guidelines, and positive ICE3 trial outcomes, while the second expands cryoablation's use to axillary lymph node metastases for …

ICCM main company

Sharemaestro market context Price below Trend Line 52 weeks -88.6% · Next-week setup negative 38.3%

13:41 13 Aug 2026

Medical Buyer Earnings Main company 🇺🇸 United States

MaxCyte revenue down 15% to USD 7.3M in Q2 2026

MaxCyte, Inc. reported its Q2 2026 financial results, showing a 15% decrease in total revenue to $7.3 million compared to Q2 2025. Despite the revenue dip, the company exceeded expectations due to strong instrument placements and stable processing assembly sales, and significantly reduced its …

MXCT main company

Sharemaestro market context Trend signal active 52 weeks -13.2% · Next-week setup negative 38.2%

13:40 13 Aug 2026

Stock Titan Balance sheet Main company 🇺🇸 United States

NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk

NeuroOne Medical Technologies (NMTC) reported a deeper net loss of $2.01 million for Q3 2026 and $5.83 million for the nine months ended June 30, 2026, significantly larger than the previous year. The company's cash and cash equivalents dwindled to $2.05 million, leading management …

NMTC main company

Sharemaestro market context Price below Trend Line 52 weeks -66.9% · Next-week setup negative 44.1%

13:40 13 Aug 2026

Investing.com India Earnings Main company 🇺🇸 United States

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com

This article announces that Neuroone Medical Technologies Corp filed a Form 8K on August 13. It includes the company's stock symbol (NMTC) and its current performance. The content primarily serves as a placeholder for the filing and does not provide further details about the …

NMTC main company

Sharemaestro market context Price below Trend Line 52 weeks -66.9% · Next-week setup negative 44.1%

13:40 13 Aug 2026

TradingView Earnings Main company 🇺🇸 United States

NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9%

NeuroOne (NMTC) reported a 16% increase in Q3 FY2026 product revenue to $1.97 million, with product gross margin expanding to 59.9%. Despite a net loss of $2.01 million, the company secured $2.7 million in new product orders and achieved ISO 13485:2016 certification. Significant progress …

NMTC main company

Sharemaestro market context Price below Trend Line 52 weeks -66.9% · Next-week setup negative 44.1%

13:40 13 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

SS Innovations Installs 30 SSi Mantra Surgical Systems in Q2

SS Innovations (Nasdaq: SSII) reported strong unaudited financial results for Q2 2026, with revenue up 39.4% year-over-year to $13.9 million, driven by SSi Mantra system sales. Despite increased revenue, the company posted a net loss of $2.7 million for the quarter. SS Innovations also …

SSII main company

Sharemaestro market context Price below Trend Line 52 weeks -43.6% · Next-week setup negative 39.1%

13:40 13 Aug 2026

GlobeNewswire Earnings Main company 🇺🇸 United States

SS Innovations Reports Second Quarter 2026 Financial Results

SS Innovations announced strong financial results for Q2 2026, with record quarterly revenue of $13.9 million, a 39.4% increase year-over-year, driven by increased sales of its SSi Mantra surgical robotic system. The company also reported significant milestones, including successful long-distance telesurgeries and industry awards, …

SSII main company

Sharemaestro market context Price below Trend Line 52 weeks -43.6% · Next-week setup negative 39.1%

13:40 13 Aug 2026

marketscreener.com Earnings Main company 🇺🇸 United States

BofA Securities Adjusts Price Target on Haemonetics to $100 From $93

BofA Securities has increased its price target for Haemonetics (HAE) to $100, up from the previous $93. This adjustment reflects a positive outlook from the firm on the medical technology company. Haemonetics specializes in solutions for critical medical needs, including hospital technologies, plasma collection, …

HAE main company

Sharemaestro market context Trend signal active 52 weeks +63.5% · Next-week setup negative 44.6%

13:40 13 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

FitLife Brands Inc. (FTLF) Beats Q2 Earnings and Revenue Estimates

FitLife Brands Inc. (FTLF) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

MDT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -4.1%

13:37 13 Aug 2026

finance.yahoo.com Analyst action Main company 🇺🇸 United States

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

ABT main company SYK main company

Sharemaestro market context Price above Trend Line 52 weeks -16.9%

13:30 13 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in …

DXCM mentioned

Sharemaestro market context Trend signal active 52 weeks +4.7%

13:13 13 Aug 2026

seekingalpha.com Earnings Main company 🇺🇸 United States

Lucid Diagnostics Non-GAAP EPS of -$0.06 misses by $0.01, revenue of $1.47M misses by $0.46M

* Lucid Diagnostics press release [https://seekingalpha.com/pr/20618076-lucid-diagnostics-provides-business-update-and-reports-second-quarter-2026-financial-results] (LUCD [https://seekingalpha.com/symbol/LUCD]): Q2 Non-GAAP EPS of -$0.06 misses by $0.01. * Revenue of $1.47M (+26.7% Y/Y) misses by $0.46M. * Processed 2,770 EsoGuard tests * Lucid had cash and cash equivalents of $33.4 million as of June 30, …

LUCD main company

Sharemaestro market context Price below Trend Line 52 weeks -5.2%

13:11 13 Aug 2026

www.marketscreener.com Analyst action Main company 🇺🇸 United States

Citigroup Upgrades Establishment Labs to Buy From Neutral, Price Target is $92

Citigroup has upgraded its rating for Establishment Labs Holdings Inc. to 'Buy' from 'Neutral', setting a new price target of $92. This upgrade follows the company's recent Q2 2026 earnings report, where it exceeded revenue estimates and raised its full-year 2026 earnings guidance. Establishment …

ESTA main company

Sharemaestro market context Trend signal active 52 weeks +102.0%

13:02 13 Aug 2026

marketscreener.com Analyst action Main company 🇺🇸 United States

Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating

Citigroup has increased its price target for Stryker (SYK) to $399 from $385, while reiterating a Buy rating on the stock. This adjustment reflects Citigroup's continued positive outlook on the medical equipment company. The article also lists other recent analyst adjustments and company news …

SYK main company

Sharemaestro market context Price above Trend Line 52 weeks -10.6%

13:01 13 Aug 2026

marketscreener.com Analyst action Main company 🇺🇸 United States

Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating

Citigroup has increased its price target for DexCom (DXCM) shares to $105 from $88, while reiterating a Buy rating on the stock. This adjustment reflects a more optimistic outlook from the firm regarding the medical equipment company. DexCom specializes in continuous glucose monitoring systems …

DXCM main company

Sharemaestro market context Trend signal active 52 weeks +4.7%

13:01 13 Aug 2026

nasdaq.com Earnings Main company 🇺🇸 United States

Haemonetics (HAE) Q1 2027 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations and Treasurer - Olga GuyetteChief Executive Officer - Christopher SimonChief Financial Officer - James D'Arecca TAKEAWAYS Net Revenue -- $339.4 million, representing 5.6% reported …

HAE main company

Sharemaestro market context Trend signal active 52 weeks +63.5% · Next-week setup negative 44.6%

12:54 13 Aug 2026

24/7 Wall St. Analyst action Main company 🇺🇸 United States

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …

ABT main company

Sharemaestro market context Price above Trend Line 52 weeks -16.9%

12:42 13 Aug 2026

Simply Wall Street Earnings Main company 🇺🇸 United States

Earnings Update: Quanterix Corporation (NASDAQ:QTRX) Just Reported And Analysts Are Trimming Their Forecasts

Quanterix Corporation recently reported disappointing second-quarter results, with revenues falling 12% short of analyst estimates and statutory losses significantly exceeding expectations. Following this, analysts have made serious cuts to their revenue outlook for 2026, now expecting a 6.8% decline, and anticipate increased losses per …

QTRX main company

Sharemaestro market context Price below Trend Line 52 weeks -11.8%

12:41 13 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

CONMED (NYSE:CNMD) Upgraded to Hold at Zacks Research

Zacks Research has upgraded CONMED (NYSE:CNMD) from a "strong sell" to a "hold" rating, despite the broader analyst consensus remaining at "Reduce" with an average price target of $41.40. This upgrade follows CONMED's strong quarterly earnings report, where it exceeded EPS and revenue estimates, …

CNMD main company

Sharemaestro market context Price above Trend Line 52 weeks -7.2% · Next-week setup negative 40.0%

12:40 13 Aug 2026

Market source Earnings Main company 🇺🇸 United States

NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%

NeuroOne Medical Technologies Corporation reported strong fiscal Q3 2026 financial results, with product revenue increasing 16% year-over-year to $2.0 million and gross margins expanding to 59.9%. The company also announced $2.7 million in new product orders, received ISO 13485 Certification for international expansion, and …

NMTC main company

Sharemaestro market context Price below Trend Line 52 weeks -66.9% · Next-week setup negative 44.1%